These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21708827)

  • 1. Kupffer cell activation and portal hypertension.
    Steib CJ
    Gut; 2011 Oct; 60(10):1307-8. PubMed ID: 21708827
    [No Abstract]   [Full Text] [Related]  

  • 2. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
    Holland-Fischer P; Grønbæk H; Sandahl TD; Moestrup SK; Riggio O; Ridola L; Aagaard NK; Møller HJ; Vilstrup H
    Gut; 2011 Oct; 60(10):1389-93. PubMed ID: 21572121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.
    Laursen TL; Rødgaard-Hansen S; Møller HJ; Mortensen C; Karlsen S; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F; Grønbaek H
    Liver Int; 2017 Apr; 37(4):569-575. PubMed ID: 27706896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension.
    Luca A; Miraglia R; Caruso S; Milazzo M; Gidelli B; Bosch J
    Liver Transpl; 2006 Aug; 12(8):1237-43. PubMed ID: 16741929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal blood flow, effective hepatic blood flow, and outcome after partial portal decompression.
    Rosemurgy AS; Thometz DP; Zervos EE
    J Surg Res; 2004 Mar; 117(1):64-70. PubMed ID: 15013716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
    De Santis A; Nardelli S; Bassanelli C; Lupo M; Iegri C; Di Ciesco CA; Forlino M; Farcomeni A; Riggio O
    J Gastroenterol Hepatol; 2018 Mar; 33(3):704-709. PubMed ID: 28753738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Han J; Huang Q; Li N; Li J
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):701-8. PubMed ID: 20703849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion.
    Mortensen C; Karlsen S; Grønbæk H; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F
    Liver Int; 2013 Oct; 33(9):1309-15. PubMed ID: 23763259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transjugular intrahepatic portosystemic shunt in treatment of portal hypertension].
    Tarazov PG
    Khirurgiia (Mosk); 1999; (7):64-9. PubMed ID: 10459195
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
    Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
    Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic porto-systemic shunt to relieve refractory ascites in a patient with cirrhosis and portal hypertension.
    Joseph G; George OK; Jayanthi V
    Indian Heart J; 2002; 54(6):731-2. PubMed ID: 12674194
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension complications].
    Xu K; Han GH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):481-2. PubMed ID: 22152232
    [No Abstract]   [Full Text] [Related]  

  • 17. Invasive and non-invasive assessment of portal hypertension.
    Leung JC; Loong TC; Pang J; Wei JL; Wong VW
    Hepatol Int; 2018 Feb; 12(Suppl 1):44-55. PubMed ID: 28361299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsuccessful transjugular intrahepatic portosystemic shunt for a patient with right heart failure and portal hypertension.
    Graus L; Verresen L; De Vusser P; Verbrugge FH; Caenepeel P
    Acta Gastroenterol Belg; 2017; 80(1):63-66. PubMed ID: 29364100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
    Carrillo-Esper R; Carrillo-Cortes U; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA; Carrillo-Córdova DM
    Cir Cir; 2013; 81(2):143-7. PubMed ID: 23522316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.